{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:09:26Z","timestamp":1789016966634,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofliquidbiopsy.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Liquid Biopsy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jlb.2026.100489","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:32:29Z","timestamp":1787067149000},"page":"100489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Liquid biopsy in oncology practice: A global survey by the Young Committee of the International Society of Liquid Biopsy (ISLB)"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5042-6550","authenticated-orcid":false,"given":"Eleonora","family":"Nicol\u00f2","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surbhi","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erick F.","family":"Saldanha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Venetis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia","family":"Pontolillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivahamy","family":"Maheswaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"de Miguel-Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Dipasquale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Ghazali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Pisapia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Ortega-Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Gouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin A.","family":"Bleiberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canio","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Stejskal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriol","family":"Mirallas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enes","family":"Erul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilberto","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi Kathy","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Borea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Reduzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jlb.2026.100489_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlb.2024.100156","article-title":"The role of liquid biopsy as a catalyst for sustained progress in precision oncology \u2013 perspective of the young committee of the international society of liquid biopsy","author":"Saldanha","year":"2024","journal-title":"J Liq Biopsy"},{"key":"10.1016\/j.jlb.2026.100489_bib2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41698-025-00876-y","article-title":"Circulating tumor DNA to monitor treatment response in solid tumors and advance precision oncology","volume":"9","author":"Bartolomucci","year":"2025","journal-title":"npj Precis Oncol"},{"key":"10.1016\/j.jlb.2026.100489_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104483","article-title":"Unveiling the impact of circulating tumor cells: two decades of discovery and clinical advancements in solid tumors","volume":"203","author":"Reduzzi","year":"2024","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jlb.2026.100489_bib4","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.annonc.2022.05.520","article-title":"ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO precision medicine working group","volume":"33","author":"Pascual","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jlb.2026.100489_bib5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13046-025-03322-w","article-title":"A scoping review of factors influencing the implementation of liquid biopsy for cancer care","volume":"44","author":"Sheriff","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.jlb.2026.100489_bib6","doi-asserted-by":"crossref","DOI":"10.1200\/PO.23.00382","article-title":"Recommendations for the equitable and widespread implementation of liquid biopsy for cancer care","author":"Febbo","year":"2024","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.jlb.2026.100489_bib7","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/jso.70045","article-title":"Clinical use of liquid biopsy in metastatic breast cancer\u2014an ESSO\u2010EYSAC international survey","volume":"132","author":"Suppan","year":"2025","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jlb.2026.100489_bib8","article-title":"Assessing oncologists' attitudes concerning comprehensive genomic profiling in stage IV lung adenocarcinoma in Brazil","volume":"3","author":"Fares","year":"2022","journal-title":"JTO Clin Res Rep"},{"key":"10.1016\/j.jlb.2026.100489_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104289","article-title":"US physician perspective on the use of biomarker and ctDNA testing in patients with melanoma","volume":"196","author":"Fischer","year":"2024","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jlb.2026.100489_bib10","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/ajco.14215","article-title":"The current status of circulating tumor DNA utilization in Australasia: a survey of thoracic oncology group Australasia members","volume":"22","author":"Zhu","year":"2026","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1016\/j.jlb.2026.100489_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2021.101681","article-title":"Practices and expectations on the use of circulating tumor DNA in colorectal cancer patients: a bi-national AGEO\/AIOM\/GERCOR\/FFCD\/FRENCH survey","volume":"45","author":"Basile","year":"2021","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jlb.2026.100489_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2026.116676","article-title":"Translating ctDNA into cutaneous melanoma care: an international expert survey","author":"Geidel","year":"2026","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jlb.2026.100489_bib13","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/j.jtho.2025.07.114","article-title":"The 2024 international association for the study of lung cancer global survey on biomarker testing","volume":"20","author":"Smeltzer","year":"2025","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jlb.2026.100489_bib16","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.annonc.2023.06.011","article-title":"ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe","volume":"34","author":"Bayle","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jlb.2026.100489_bib17","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1093\/annonc\/mdx521","article-title":"ESMO international consortium study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in countries outside of Europe","volume":"28","author":"Cherny","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jlb.2026.100489_bib18","doi-asserted-by":"crossref","first-page":"609","DOI":"10.6004\/jnccn.2023.7011","article-title":"Private payer and medicare coverage policies for use of circulating tumor DNA tests in cancer diagnostics and treatment","volume":"21","author":"Douglas","year":"2023","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.jlb.2026.100489_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.757212","article-title":"Limited genomics training among physicians remains a barrier to genomics-based implementation of precision medicine","volume":"9","author":"Schaibley","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.jlb.2026.100489_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104776","article-title":"Cancer in a drop: advances in liquid biopsy in 2024","volume":"213","author":"Borea","year":"2025","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jlb.2026.100489_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.116050","article-title":"International expert consensus on the clinical integration of circulating tumor cells in solid tumors","volume":"231","author":"Nicol\u00f2","year":"2025","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jlb.2026.100489_bib22","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41416-024-02709-4","article-title":"Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancer","volume":"131","author":"Malapelle","year":"2024","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jlb.2026.100489_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlb.2025.100301","article-title":"International society of liquid biopsy (ISLB) perspective on minimal requirements for ctDNA testing in solid tumors","volume":"8","author":"Fusco","year":"2025","journal-title":"J Liq Biopsy"},{"key":"10.1016\/j.jlb.2026.100489_bib24","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jmoldx.2025.08.011","article-title":"Developing consensus for a more provider-friendly next-generation sequencing molecular biomarker report: a joint consensus recommendation of the association for molecular pathology and college of American pathologists","volume":"27","author":"Gibson","year":"2025","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jlb.2026.100489_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2018-000398","article-title":"Multidisciplinary molecular tumour board: a tool to improve clinical practice and selection accrual for clinical trials in patients with cancer","volume":"3","author":"Rolfo","year":"2018","journal-title":"ESMO Open"},{"key":"10.1016\/j.jlb.2026.100489_bib26","doi-asserted-by":"crossref","DOI":"10.2147\/CEOR.S220726","article-title":"Analysis of the cost-effectiveness of liquid biopsy to determine treatment change in patients with Her2-Positive advanced breast cancer in Colombia","volume":"12","author":"S\u00e1nchez-Calder\u00f3n","year":"2020","journal-title":"Clinicoecon Outcomes Res"},{"key":"10.1016\/j.jlb.2026.100489_bib27","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s00432-022-04034-w","article-title":"Clinical benefit and cost-effectiveness analysis of liquid biopsy application in patients with advanced non-small cell lung cancer (NSCLC): a modelling approach","volume":"149","author":"Englmeier","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.jlb.2026.100489_bib28","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1053\/j.gastro.2024.03.011","article-title":"Comparative effectiveness and cost-effectiveness of colorectal cancer screening with blood-based biomarkers (Liquid Biopsy) vs fecal tests or colonoscopy","volume":"167","author":"Ladabaum","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jlb.2026.100489_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2024.107794","article-title":"The cost-effectiveness of including liquid biopsy into molecular profiling strategies for newly diagnosed advanced non-squamous non-small cell lung cancer in an Asian population","volume":"191","author":"Liu","year":"2024","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jlb.2026.100489_bib30","doi-asserted-by":"crossref","DOI":"10.1177\/17562848241248246","article-title":"Explorative cost-effectiveness analysis of colorectal cancer recurrence detection with next-generation sequencing liquid biopsy in Spain, France, and Germany","volume":"17","author":"Schramm","year":"2024","journal-title":"Therapeut Adv Gastroenterol"},{"key":"10.1016\/j.jlb.2026.100489_bib31","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jval.2020.02.001","article-title":"Use of real-world evidence in US payer coverage decision-making for next-generation sequencing\u2013based tests: challenges, opportunities, and potential solutions","volume":"23","author":"Deverka","year":"2020","journal-title":"Value Health"},{"key":"10.1016\/j.jlb.2026.100489_bib32","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s40258-021-00714-9","article-title":"Financing and reimbursement models for personalised medicine: a systematic review to identify current models and future options","volume":"20","author":"Koleva-Kolarova","year":"2022","journal-title":"Appl Health Econ Health Pol"},{"key":"10.1016\/j.jlb.2026.100489_bib33","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41698-025-00865-1","article-title":"Systematic review and meta-analysis of molecular tumor board data on clinical effectiveness and evaluation gaps","volume":"9","author":"Gladstone","year":"2025","journal-title":"npj Precis Oncol"},{"key":"10.1016\/j.jlb.2026.100489_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.102978","article-title":"Challenges and opportunities of cfDNA analysis implementation in clinical practice: perspective of the international society of liquid biopsy (ISLB)","volume":"151","author":"Rolfo","year":"2020","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["The Journal of Liquid Biopsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950195426000354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950195426000354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:31:03Z","timestamp":1789014663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950195426000354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":32,"alternative-id":["S2950195426000354"],"URL":"https:\/\/doi.org\/10.1016\/j.jlb.2026.100489","relation":{},"ISSN":["2950-1954"],"issn-type":[{"value":"2950-1954","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liquid biopsy in oncology practice: A global survey by the Young Committee of the International Society of Liquid Biopsy (ISLB)","name":"articletitle","label":"Article Title"},{"value":"The Journal of Liquid Biopsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jlb.2026.100489","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of The International Society of Liquid Biopsy.","name":"copyright","label":"Copyright"}],"article-number":"100489"}}